Michael Dybbs
CIK 1601264 · last filed 2026-06-11
Michael Dybbs is a corporate insider who has filed 25 SEC Form 4 insider transactions across 6 companies since 2014. The most recent filing, for NKTX, was dated Jun 11, 2026. Across all open-market trades the lifetime net is +$12.5M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
6
25
$12.50M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NKTX | Director | — | $2.86 | — | $0 | 7 | 2026-06-11 |
| STRO | Director | — | $28.80 | — | $0 | 10 | 2026-06-09 |
| KLRS | Director | — | $4.33 | — | $0 | 2 | 2026-06-04 |
| SGP | Director | — | $18.44 | — | $0 | 1 | 2026-02-09 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Director | 1,097,745 | — | — | $12.50M | 4 | 2017-11-07 |
| Aravive, Inc. (VSAR) Delisted | Director | — | — | — | $0 | 1 | 2014-03-24 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2026-06-09 | STRO | Grant (A) | — | $0 | EDGAR |
| 2026-06-04 | KLRS | Grant (A) | — | $0 | EDGAR |
| 2026-02-09 | SGP | Grant (A) | — | $0 | EDGAR |
| 2025-12-29 | STRO | Grant (A) | — | $0 | EDGAR |
| 2025-06-10 | STRO | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2025-04-11 | KLRS | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-10 | STRO | Grant (A) | — | $0 | EDGAR |